Term Pregnancy Women with Human Immunodeficiency Virus Infection Receiving Antiretroviral Threapy as A Risk Factor for Low Expression of Mitochondiral Deoxyribose-Nucleic Acid in Placenta
Article Main Content
Antiretroviral therapy (ART) given to pregnant women with Human Immunodeficiency Virus (HIV) has the effect of mitochondrial DNA (mtDNA) depletion through several steps, either directly or indirectly. This decrease may trigger the occurrence of reactive oxygen species (ROS) and mitochondrial toxicity which are characterized by energy insufficiency, cell dysfunction, and maternal and placental apoptosis. This study aimed to determine whether term pregnant women with HIV infection receiving antiretroviral therapy are risk factors for low mtDNA expression in the placenta. This cross-sectional analytic study was conducted at Sanglah Hospital Denpasar and affiliation hospitals. Inclusion samples were termed pregnant women with HIV (+) who received ART ≥ 6 months as a risk group and pregnant women with HIV (-) as a non-risk group. Expression of mtDNA was assessed by real-time Polymerase Chain Reaction (rtPCR) examination of placental samples. The estimated relative amount of mtDNA was calculated by dividing the number of mtDNA to the number of nDNA, as a reference. The cut-off value of mtDNA expression was determined by plotting a Receiver Operating Characteristics (ROC) curve. The results of the analysis found that pregnant women with HIV who received ART≥6 months had a prevalence of low mtDNA expression by 2.83 times higher than pregnant women without HIV (95% confidence interval = 1.42 – 5.67; p-value = 0.000). The conclusion of this study is that term pregnant women with HIV infection who receive ART is a risk factor for low mtRNA expression in the placental.
References
-
Siregar KN, Hanifah L, Rikawarastuti, Wahyuniar L. Prevention of HIV Transmission from Mother to Child: Challenges to the Successful Program Implementation and Practice in Indonesia. J Int Assoc Provid AIDS Care. 2021; 20: 23259582211040701.
DOI |
Google Scholar
1
-
Stover J, Glaubius R, Teng Y, Kelly S, Brown T, Hallett TB, et al. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Med. 2021; 18(10): e1003831.
DOI |
Google Scholar
2
-
Badru O, Dairo MD, Oladokun RE. Quality of Life of HIV Infected Children Attending the Antiretroviral Clinic, University College Hospital, Ibadan. West Afr J Med. 2020; 37(5): 521-527.
Google Scholar
3
-
Morén C, Hernández S, Guitart-Mampel M, Garrabou G. Mitochondrial Toxicity in Human Pregnancy: An Update on Clinical and Experimental Approaches in the Last 10 Years. International Journal of Environmental Research and Public Health, 2014; 11(9): hh.9897-9918
DOI |
Google Scholar
4
-
Money D, Wagner E, Maan E, Chaworth-Musters T, Gadawski I, van Schalkwyk J, et al. Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women. Plos One. 2015; 10(8): h.e0135041.
DOI |
Google Scholar
5
-
Vermaak A, Theron G, Schubert P, Kidd M, Rabie U, Adjiba B, et al. Morphologic Changes in the Placentas of HIV-Positive Women and Their Association with Degree of Immune Suppression. International Journal of Gynecology & Obstetrics. 2012; 119(3): hh.239-243.
DOI |
Google Scholar
6
-
Ekouevi DK, Stringer E, Coetzee D, Tih P, Creek T, Stinson K, et al. Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study. PLoS One. 2012; 7(1): e29823.
DOI |
Google Scholar
7
-
Negara IKS, Anantasika AAN, dan Putra IWA. Characteristics of pregnant women with HIV infection following prevention of mother to child transmission of HIV (PMTCT) program in Sanglah general hospital 2005-2014. Bali Med J. 2016; 5(1): 147-151.
DOI |
Google Scholar
8
-
Sofiyanti I, Astuti FP. Relationship between the characteristics of pregnant women and HIV testing. Indonesian Journal of Midwivery. 2018; 1(1): 49-52.
DOI |
Google Scholar
9
-
Hernández S, Moren C, Catalán-García M, Lopez M, Guitart-Mampel M, Coll O, et al. Mitochondrial toxicity and caspase activation in HIV pregnant women. Journal of Cellular and Molecular Medicine. 2017; 21(1): hh. 26-34.
DOI |
Google Scholar
10
-
Young S, Murray K, Mwesigwa J, Natureeba P, dan Osterbauer B. Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy. Plos ONE. 2012; 7(8): e41934.
DOI |
Google Scholar
11
-
van der Heijden WA, van de Wijer L, Jaeger M, et al. Long-term treated HIV infection is associated with platelet mitochondrial dysfunction. Sci Rep. 2021;11(1):6246. Published 2021 Mar 18. doi:10.1038/s41598-021-85775-5
DOI |
Google Scholar
12
-
Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, et al. (2003) Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 32: 370–374.
DOI |
Google Scholar
13
-
Guitart-MampeL M, Hernandez AS, Moren C, Catalan-Garcia M, Tobias E, Gonzalez-Casacuberta I, et al. Imbalance in Mitochondrial Dynamics and Apoptosis in Pregnancies Among HIV-Infected Women on HAART with Obstetric Complications. J Antimicrob Chemother. 2017; 72: hh. 2578-2586.
DOI |
Google Scholar
14
-
Ordono MS. Placental Mitochondral Dysfunction in Relation to Preterm Delivery in HIV Pregnancy. M. S. Thesis. University of British Columbia. 2014.
Google Scholar
15
Most read articles by the same author(s)
-
Anak Agung Ngurah Jaya Kusuma,
I Made Darmayasa,
Endang Sri Widiyanti,
I Gede Bagus Arya Maharta,
High C-Reactive Protein Serum Levels as a Risk Factor for Preeclampsia , European Journal of Medical and Health Sciences: Vol. 6 No. 4 (2024) -
I Nyoman Bayu Mahendra,
Bagus Ngurah Brahmantara,
William Alexander Setiawan,
A Review of Current Management of Gestational Trophoblastic Disease , European Journal of Medical and Health Sciences: Vol. 4 No. 5 (2022) -
I Made Darmayasa,
William Alexander Setiawan,
Raymond Josafat Major Natanael,
Post-Trauma Stress Disorder in Sexual Harassment: A Case Report , European Journal of Medical and Health Sciences: Vol. 5 No. 2 (2023) -
I Nyoman Bayu Mahendra,
William Alexander Setiawan,
Current Management of CINV , European Journal of Medical and Health Sciences: Vol. 5 No. 3 (2023) -
I Nyoman Bayu Mahendra,
Erliana Fani,
I Nyoman Gede Budiana,
I Wayan Megadhana,
Made Bagus Dwi Aryana,
I Gde Sastra Winata,
Correlation Between E6 and E7 Oncogene Mutation Human Papilloma Virus High Risk Type 16 with Retinoblastoma Protein Expression in Cervical Cancer , European Journal of Medical and Health Sciences: Vol. 4 No. 6 (2022) -
I Gede Mega Putra,
I Wayan Megadhana,
I Made Darmayasa,
Made Nathassa Karisma,
Case Series: Iatrogenic Rupture of The Bladder , European Journal of Medical and Health Sciences: Vol. 4 No. 4 (2022) -
I Made Darmayasa,
Ni Luh Putu Padmawati,
Quality of Life of Patients with Advanced Stage Ovarian Cancer from Sanglah Hospital Denpasar: Serial Case Report , European Journal of Medical and Health Sciences: Vol. 4 No. 3 (2022) -
I Made Darmayasa,
Made Bagus Dwi Aryana,
William Alexander Setiawan,
Gede Eka Rusdi Antara,
Gossypiboma Post Cesarean Section: Patient Safety Review , European Journal of Medical and Health Sciences: Vol. 5 No. 5 (2023) -
I Made Darmayasa,
William Alexander Setiawan,
Wati Evilia,
Feby Ubro,
Psycho-Social Impact of Stigmatization against Pregnant Women with HIV , European Journal of Medical and Health Sciences: Vol. 5 No. 4 (2023) -
I Gusti Made Kusuma Widnyana,
I Wayan Artana Putra,
Tjokorda G. A. Suwardewa,
Putu Doster Mahayasa,
I Made Darmayasa,
I Gde Sastra Winata,
Aterm Pregnant Women with Human Immunodeficiency Virus Infection Which Receive Antiretroviral Therapy Combination of Nucleoside Analogue Reverse Transcriptase Inhibitor as A Risk Factor of High Expression of Apoptosis Including Factors , European Journal of Medical and Health Sciences: Vol. 4 No. 3 (2022)